Table of Contents Table of Contents
Previous Page  S271 S290 Next Page
Information
Show Menu
Previous Page S271 S290 Next Page
Page Background

patella, and bilateral medial/lateral ankles. Range of motion,

strength, reflexes, and sensation were normal. X-rays of bilateral

knees/ankles and DEXA scan were unremarkable. Bone scan showed

diffuse mildly increased tracer uptake in bilateral distal femurs and

proximal tibias. MRI showed bilateral patellofemoral and medial

chondral disease.

Setting:

Outpatient.

Results:

Patient was suspected to have calcineurin inhibitor induced

pain syndrome (CIPS). Due to hepatic steatosis, she couldn’t be

switched to another immunosuppressant. Patient reported improved

pain and standing/walking tolerance with calcitonin-salmon nasal

spray and increased dose of gabapentin 800-mg daily. Patient also

started acupuncture and reported 90% improvement in pain after

initial session.

Discussion:

CIPS is a rare disabling syndrome that should be consid-

ered in immunosuppressed patients with LE pain. This case illustrates

a patient with previously reported characteristic clinical features of

CIPS in addition to uncharacteristic neuropathic symptoms and imaging

findings. There have been several proposed hypotheses for pain

development including calcineurin inhibitor induced vascular distur-

bance, bone remodeling, and nociceptive modulation. These may all

contribute to the development of pain and account for the variation in

clinical symptoms and imaging findings. Also, there have been no

previous reports of acupuncture treatment for CIPS which provided

significant pain relief for our patient. Additional research into pain

generating mechanisms of calcineurin inhibitors may identify further

treatment options.

Conclusions:

Early recognition and management of CIPS can improve

quality of life. Further research into CIPS may provide additional and

more specific diagnosis/management guidelines.

Level of Evidence:

Level V

Poster 436:

Chemotherapy-Induced Peripheral Neuropathy Pain

and Postmastectomy Pain Syndrome in a Breast

Cancer Patient Managed with Neurostimulation: A

Case Report

Thomas Chai, MD (UT MD Anderson Cancer Center, Houston, TX,

United States), Siddarth Thakur, MD, Girish S. Shroff, MD

Disclosures:

Thomas Chai: I Have No Relevant Financial Relationships

To Disclose

Case/Program Description:

A 57-year-oldwomanwith oncologic history

of breast cancer, s/p neoadjuvant chemotherapy, left total mastectomy,

and postoperative radiation therapy presents with chronic peripheral

neuropathic pain affecting the hands and feet since chemotherapy, and

chronic left arm pain/lymphedema since surgery and radiation therapy.

Her pain medication regimen included opioids, non-opioids, and adju-

vants, without adequate analgesia. She also underwent stellate ganglion

blocks, with minimal improvement in her pain. For refractory pain, the

patient was deemed an appropriate candidate for, and agreed to, a

neurostimulator trial, utilizing two cervical octrode leads at the C4

vertebral body level to capture upper limb pain, and two octrode thoracic

leads at the T8 vertebral body level to capture lower limb pain.

Setting:

Tertiary care hospital.

Results:

The neurostimulator trial was considered a success, as the

patient reported at least 50% relief in areas of her painful upper and

lower limbs, and the patient subsequently proceeded to permanent

spinal cord stimulator implantation surgery.

Discussion:

Chemotherapy is directly toxic to peripheral nerves and can

result inpainful peripheral neuropathy that can affect the hands and feet,

often progressing to involve a stocking-glove sensory distribution. This

pain can lead to cessation of chemotherapy, in severe cases. The symp-

toms may persist after treatment, becoming a chronic pain issue for the

cancer patient. In addition, after mastectomy surgery, hemithoracic and

upper limb pain may occur, and if it persists, leads to a chronic

neuropathic pain condition called postmastectomy pain syndrome. This

syndrome may in part be due to injury to the intercostobrachial nerve

during surgery. Radiation therapy is a risk factor. The presence of lym-

phedema in the affected part may aggravate the condition.

Conclusions:

Neurostimulation may be worth considering for both

chemotherapy-induced peripheral neuropathy pain and post-

mastectomy pain syndrome resistant to pharmacologic management.

Level of Evidence:

Level V

Poster 437:

Pain Associated with Trigeminal Neuralgia Effectively

Treated with Kinesio Taping: A Case Report

Benjamin Tracy, MD (University of Rochester Medical Center,

Rochester, NY, United States), Edward Lam, MD, Sara Salim, MD

Disclosures:

Benjamin Tracy, MD: I Have No Relevant Financial Re-

lationships To Disclose

Case/Program Description:

The patient presented with autoimmune

anti-TNF associated demyelination polyneuropathy and trigeminal

neuralgia. Her trigeminal neuralgia pain had previously been

controlled with oxcarbazepine but this was discontinued due to

significantly decreased IgG levels. Consequently, she experienced

significant burning pain and discomfort in her right jaw, cheek and

neck from her trigeminal neuralgia which escalated to the point of

interfering with her ability to participate in her scheduled 3 hours of

daily therapy. She had a complex pharmacologic pain regimen that

included: nortriptyline, acetaminophen, baclofen, cyclobenzaprine,

gabapentin, fentanyl patch, and hydromorphone PRN. Topical agents

were then tried with both lidocaine and diclofenac gel not being

effective. Neurology was consulted and recommended a gasserian

ganglion block be performed by interventional radiology, which the

patient declined. After discussion with multiple teams on the different

non-invasive treatments therapeutic kinesio taping was initiated.

After treatment, the patient reported a significant reduction in her

trigeminal neuralgia pain and was able to participate in therapy.

Setting:

Acute inpatient rehabilitation facility.

Results:

Utilizing the same technique as would be done for applying

kinesiology tape for TMJ, kinesio taping was done on the patient. The

following day the patient reported a 75% reduction in her trigeminal

neuralgia pain. She was also able to reduce her Hydromorphone usage

from approximately 6 times a day to only 1-2 times a day, and had

improved participation in therapy.

Discussion:

This is the first reported case, to our knowledge, of a

patient being treated with kinesiology tape for pain associated with

trigeminal neuralgia.

Conclusions:

Kinesio taping may be an effective treatment for tri-

geminal neuralgia pain and further research is warranted.

Level of Evidence:

Level V

Poster 438:

Management of Low Back Pain in Pediatric Male with

Multilevel Vertebral Body Compression Fractures: A

Case Report

Michael J. Bonnette, MD (WA Univ/BJH/SLCH Consortium),

Jacob AuBuchon, MD

Disclosures:

Michael Bonnette: I Have No Relevant Financial Re-

lationships To Disclose

Case/Program Description:

The patient is a 14-year-old male with a

distant history of T-cell Leukemia status post radiation, chemotherapy,

and bone marrow transplant, complicated by graft versus host disease

requiring long-term steroid usage who presented to the Pain Manage-

ment Clinic with acute worsening of long standing back pain. He also

had previously known multiple vertebral fractures and required bracing

and conservative management at the age of 7 for pain management. His

S271

Abstracts / PM R 9 (2017) S131-S290